• P Zimmet and
• S Whitehouse

Bimodality of fasting and two-hour glucose tolerance distributions in a Micronesian population.

• S Pek,
• T Y Tai,
• and A Elster

Stimulatory effects of prostaglandins E-1, E-2, and F-2-alpha on glucagon and insulin release in vitro.

• J K Davidson,
• D Reuben,
• J C Sternberg,
• and W T Ryan

Diabetes screening using a quantitative urine glucose method.

• D G Pipeleers,
• M A Pipeleers-Marichal,
• I E Karl,
• and D M Kipnis

Secretory capability of islets transplanted intraportally in the diabetic rat.

• A E Lambert,
• M Buysschaert,
• E Marchand,
• M Pierard,
• S Wojcik,
• and L Lambotte

Determination of insulin requirements in brittle diabetic patients by the artificial pancreas.

• R J Graf,
• J B Halter,
• and D Porte, Jr

Glycosylated hemoglobin in normal subjects and subjects with maturity-onset diabetes. Evidence for a saturable system in man.

• R J Bucolo

Obesity, hyperinsulinemia, and portal blood flow. A theoretic study of the effects of increased portal blood flow upon fasting peripheral insulin concentrations.

• J M May and
• R H Williams

The effect of endogenous gastric inhibitory polypeptide on glucose-induced insulin secretion in mild diabetes.

• G F Tutwiler,
• T Kirsch,
• and G Bridi

A pharmacologic profile of McN-3495 [N-(1-methyl-2-pyrrolidinylidene)-N'-phenyl-1-pyrrolidinecarboximidamide], a new, orally effective hypoglycemic agent.

• G F Tutwiler and
• G Bridi

Comparison of McN-3495 [N-(1-methyl-2-pyrrolidinylidene)-N'-phenyl-1-pyrrolidinecarboximidamide], a new, orally effective, hypoglycemic agent, with the biguanides.

Policy statement. Recombinant DNA research.

Policy statement. Saccharin.